Literature DB >> 11793032

Hyperthermia-induced HSP expression correlates with improved rat renal isograft viability and survival in kidneys harvested from non-heart-beating donors.

C A Redaelli1, M Wagner, C Kulli, Y H Tian, D Kubulus, L Mazzucchelli, A C Wagner, M K Schilling.   

Abstract

Transient sublethal hyperthermia followed by recovery from heat stress, referred to as heat shock preconditioning, exerts a protective effect on ischemia/reperfusion-induced injury in many systems. This effect is considered to be correlated to heat shock proteins (HSPs) and might be a critical factor in kidney graft function and survival. This study was designed to examine the impact of heat shock preconditioning on kidney isograft function and survival in a model utilizing non-heart-beating (NHB) donors. Four groups of male Lewis rats (n = 10/group) subjected either to whole body hyperthermia (groups A and C) or to sham anesthesia (groups B and D) were allowed 24 h recovery. Thereafter, 20 min of warm ischemia (A/B), and in a separate set of experiments 40 min of warm ischemia (C/D), were induced by suprarenal aortic cross clamping before renal procurement. After 24-h preservation with University of Wisconsin solution at 4 degrees C, orthotopic kidney transplantations were performed to syngeneic bilaterally nephrectomized recipients. Tissue specimens were taken to determine HO-1/HSP32, 72, and 90 induction by Western blot analysis. Renal function was measured by means of serum creatinine and creatinine clearance on days 0, 3, and 7 as well as urine volume, protein content, and creatinine levels daily. HO-1/HSP32 and HSP72 were found to be expressed constitutively. Moreover, heat shock strongly induced renal HSP72 and HSP32/HO-1, and to a lesser extent HSP90, expression. For recipients of group A grafts, the graft survival rate was 10/10, whereas it was 7/10 (70 %) in recipients of group B grafts (log rank p < 0.05). Following 40 min of warm ischemia, 6/10 (60 %) recipients survived, whereas all sham treated animals died with anuria within 6 days (log rank p = 0.01). Heat shock preconditioning strongly improved graft viability and reduced functional impairment. Creatinine clearance (CRC) on day 3 post Tx was 0.43 +/- 0.24 ml/min in preconditioned animals (group A) and 0.07 +/- 0.09 ml/min (p < 0.001) in sham preconditioned (group B), whereas it was 0.91 +/- 0.33 ml/min and 0.03 +/- 0.02 ml/min (p < 0.00 001) on day 7 post Tx. Following 40 min NHB time, CRC in survivors of preconditioned graft recipients (group C) was 0.32 +/- 0.2 ml/min (day 3 post Tx) and 0.23 +/- 0.08 ml/min (day 7 post Tx) and was significantly better than CRC of group B (p < 0.01 and p < 0.00001, respectively). CRCs prior to NHB procedures were comparable in all animals ranging between 1.31 and 1.72 ml/min. Serum creatinine as well as proteinuria were significantly increased after transplantation in both groups but recovered within 5 days in recipients of preconditioned grafts, whereas kidneys from donors without HP did not recover function. Histological alterations were also diminished following HP. Hyperthermic preconditioning induces strong and long lasting HO-1/HSP32, HSP72, and HSP90 expression in rat kidneys. HP increases survival following transplantation and improves renal graft function including proteinuria, volume output, and creatinine clearance. HSP induction might be used to develop novel approaches in clinical transplantation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11793032     DOI: 10.1007/s001470100000

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  12 in total

Review 1.  Heat-shock protein 70: molecular supertool?

Authors:  Christoph Aufricht
Journal:  Pediatr Nephrol       Date:  2005-03-22       Impact factor: 3.714

2.  Ethical considerations in the application of preconditioning to solid organ transplantation.

Authors:  S J McNally; E M Harrison; S J Wigmore
Journal:  J Med Ethics       Date:  2005-11       Impact factor: 2.903

3.  Short-term hyperthermia prevents activation of proinflammatory genes in fibroblast-like synoviocytes by blocking the activation of the transcription factor NF-kappaB.

Authors:  Marica Markovic; Karl M Stuhlmeier
Journal:  J Mol Med (Berl)       Date:  2006-09-06       Impact factor: 4.599

4.  Heat shock preconditioning reduces ischemic tissue necrosis by heat shock protein (HSP)-32-mediated improvement of the microcirculation rather than induction of ischemic tolerance.

Authors:  Yves Harder; Michaela Amon; Rene Schramm; Mirko Georgi; Andrej Banic; Dominique Erni; Michael D Menger
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

5.  Urinary heat shock protein-72 excretion in clinical and experimental renal ischemia.

Authors:  Thomas Mueller; Bettina Bidmon; Patrick Pichler; Klaus Arbeiter; Dagmar Ruffingshofer; Scott K VanWhy; Christoph Aufricht
Journal:  Pediatr Nephrol       Date:  2002-12-19       Impact factor: 3.714

Review 6.  Heat shock proteins in the genitourinary system.

Authors:  R William G Watson; Thierry Lebret; John M Fitzpatrick
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 2.862

Review 7.  Heat shock proteins in chronic kidney disease.

Authors:  Kinga Musiał; Danuta Zwolińska
Journal:  Pediatr Nephrol       Date:  2010-12-31       Impact factor: 3.714

Review 8.  Non-linear actions of physiological agents: Finite disarrangements elicit fitness benefits.

Authors:  Filip Sedlic; Zdenko Kovac
Journal:  Redox Biol       Date:  2017-05-18       Impact factor: 11.799

9.  Brain death induces renal expression of heme oxygenase-1 and heat shock protein 70.

Authors:  Leon F A van Dullemen; Eelke M Bos; Theo A Schuurs; Harm H Kampinga; Rutger J Ploeg; Harry van Goor; Henri G D Leuvenink
Journal:  J Transl Med       Date:  2013-01-29       Impact factor: 5.531

10.  Hyperbaric oxygen preconditioning induces tolerance against oxidative injury and oxygen-glucose deprivation by up-regulating heat shock protein 32 in rat spinal neurons.

Authors:  Guoyang Huang; Jiajun Xu; Li Xu; Shifeng Wang; Runping Li; Kan Liu; Juan Zheng; Zhiyu Cai; Kun Zhang; Yuandeng Luo; Weigang Xu
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.